Infektiologische Notfälle – Fokus Sepsis

Die Sepsis ist ein häufiges und relevantes Krankheitsbild im klinischen Alltag, speziell in der Notfall- und Intensivmedizin. Als lebensbedrohlicher Notfall betrifft die Sepsis sowohl die konservativen Fächer als auch die chirurgischen Disziplinen. Die Symptome einer Sepsis sind vielgestaltig und präsentieren sich anfangs oft unspezifisch. Gleichzeitig profitieren die Patienten von einer frühzeitigen Therapie.

Schlüsselwörter

Sepsis - septischer Schock - Infektion - Antibiotika - Sonografie

• Literatur

• 1 Singer M, Deutschman CS, Seymour CW. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801-810 doi:10.1001/jama.2016.0287
• 2 Seymour CW, Liu VX, Iwashyna TJ. et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 762-774 doi:10.1001/jama.2016.0288
• 3 SepNet Critical Care Trials Group. Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. Intensive Care Med 2016; 42: 1980-1989 doi:10.1007/s00134-016-4504-3
• 4 Bodmann K-F, Grabein B, Kresken M. et al. S2k-Leitlinie: Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen AWMF-Registernummer 082-006. Im Internet: https://www.awmf.org/uploads/tx_szleitlinien/082-006l_S2k_Parenterale_Antibiotika_2019-1.pdf Stand: 04.02.2019
• 5 Hedlund J, Kalin M, Johansson N. et al. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 2010; 50: 202-209 doi:10.1086/648678
• 6 Vincent JL, Rello J, Marshall J. et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302: 2323-2329 doi:10.1001/jama.2009.1754
• 7 Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence 2014; 5: 4-11 doi:10.4161/viru.27372
• 8 Coudroy R, Jamet A, Frat JP. et al. Incidence and impact of skin mottling over the knee and its duration on outcome in critically ill patients. Intensive Care Med 2014; 41: 452-459 doi:10.1007/s00134-014-3600-5
• 9 Cecconi M, Hernandez G, Dunser M. et al. Fluid administration for acute circulatory dysfunction using basic monitoring: narrative review and expert panel recommendations from an ESICM task force. Intensive Care Med 2019; 45: 21-32 doi:10.1007/s00134-018-5415-2
• 10 Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med 2018; 44: 925-928 doi:10.1007/s00134-018-5085-0
• 11 Rhodes A, Evans LE, Alhazzani W. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017; 43: 304-377 doi:10.1007/s00134-017-4683-6
• 12 Kumar A, Roberts D, Wood KE. et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-1596 doi:10.1097/01.Ccm.0000217961.75225.E9
• 13 Bloos F, Rüddel H, Thomas-Rüddel D. et al. Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Intensive Care Med 2017; 43: 1602-1612 doi:10.1007/s00134-017-4782-4
• 14 Sandiumenge A, Diaz E, Bodi M. et al. Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of “The Tarragona Strategy”. Intensive Care Med 2003; 29: 876-883 doi:10.1007/s00134-003-1715-1
• 15 Haas SA, Lange T, Saugel B. et al. Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients. Intensive Care Medicine 2016; 42: 202-210 doi:10.1007/s00134-015-4127-0
• 16 Wacker C, Prkno A, Brunkhorst FM. et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013; 13: 426-435 doi:10.1016/S1473-3099(12)70323-7
• 17 Branche A, Neeser O, Mueller B. et al. Procalcitonin to guide antibiotic decision making. Curr Opin Infect Dis 2019; 32: 130-135 doi:10.1097/QCO.0000000000000522
• 18 Frankel HL, Kirkpatrick AW, Elbarbary M. et al. Guidelines for the Appropriate Use of Bedside General and Cardiac Ultrasonography in the Evaluation of Critically Ill Patients-Part I: General Ultrasonography. Crit Care Med 2015; 43: 2479-2502 doi:10.1097/CCM.0000000000001216
• 19 Levitov A, Frankel HL, Blaivas M. et al. Guidelines for the Appropriate Use of Bedside General and Cardiac Ultrasonography in the Evaluation of Critically Ill Patients-Part II: Cardiac Ultrasonography. Crit Care Med 2016; 44: 1206-1227 doi:10.1097/CCM.0000000000001847
• 20 Teboul JL, Saugel B, Cecconi M. et al. Less invasive hemodynamic monitoring in critically ill patients. Intensive Care Med 2016; 42: 1350-1359 doi:10.1007/s00134-016-4375-7
• 21 Saugel B, Vincent JL. Cardiac output monitoring: how to choose the optimal method for the individual patient. Curr Opin Crit Care 2018; 24: 165-172 doi:10.1097/MCC.0000000000000492
• 22 Monnet X, Marik P, Teboul JL. Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive Care Med 2016; 42: 1935-1947 doi:10.1007/s00134-015-4134-1
• 23 Semler MW, Self WH, Wanderer JP. et al. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med 2018; 378: 829-839 doi:10.1056/NEJMoa1711584
• 24 Silversides JA, Major E, Ferguson AJ. et al. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med 2017; 43: 155-170 doi:10.1007/s00134-016-4573-3
• 25 Annane D, Ouanes-Besbes L, de Backer D. et al. A global perspective on vasoactive agents in shock. Intensive Care Med 2018; 44: 833-846 doi:10.1007/s00134-018-5242-5
• 26 Häussler U, Riessen R, Haap M. Spielen Vitamine bei der Pathogenese und Therapie der Sepsis eine Rolle?. Dtsch Med Wochenschr 2018; 143: 1450-1454 doi:10.1055/a-0661-1112
• 27 Donnino MW, Andersen LW, Chase M. et al. Randomized, Double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study. Crit Care Med 2016; 44: 360-367 doi:10.1097/CCM.0000000000001572
• 28 Marik PE, Khangoora V, Rivera R. et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest 2017; 151: 1229-1238 doi:10.1016/j.chest.2016.11.036